Amy DuRoss, Vineti CEO (Vineti)

Ex­clu­sive: An in­dus­try con­sor­tium wants to stan­dard­ize cell track­ing for re­gen­er­a­tive meds. Could that avert a dis­as­ter?

In the fast-mov­ing world of re­gen­er­a­tive med­i­cine, the open se­cret among in­dus­try ex­perts is that man­u­fac­tur­ing is ex­ceed­ing­ly dif­fi­cult and will take a Her­culean ef­fort …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.